Short Interest in JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Drops By 19.7%

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 338,200 shares, a decrease of 19.7% from the January 15th total of 421,200 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

JCR Pharmaceuticals Stock Performance

JCRRF opened at $4.57 on Monday. JCR Pharmaceuticals has a 12 month low of $4.30 and a 12 month high of $4.70. The business has a 50-day moving average of $4.57 and a two-hundred day moving average of $4.54.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.